“From Rare to Care: Discovery, Modeling and Translation of Rare Diseases” will take place at the
Vienna BioCenter from 11 to 14 November 2018 and is organized by Josef Penninger from IMBA and
Kym Boycott of Canada’s CHEO Research Institute.

View the organizer interview here.

The conference will examine the current and future bottlenecks to gene discovery, disease modeling, and therapeutic approaches for the estimated 7,000 known rare diseases, and suggest strategies to accelerate progress in this regard.

For more information on the program, speakers and deadlines, and to submit an abstract or register, please visit www.keystonesymposia.org/18S4.

Please note that scholarships for students and postdocs are available.

Keystone Symposia on Cellular and Molecular Biology is based in Silverthorne, Colorado (USA). Founded in 1972, it convenes open, peer-reviewed conferences across a broad range of the life sciences. Keystone Symposia organized its first meeting in Europe in Cambridge (UK) in 2006 and held its first conference on rare diseases in March 2017 in Boston, Massachusetts, USA. The same year, Keystone Symposia announced that Vienna Biocenter would become a regular venue for annual symposia in Europe.

Developed in collaboration with Vienna BioCenter research institutes GMI, IMBA,
IMP and MFPL

Keystone Symposia in collaboration with Vienna BioCenter is pleased to announce the inaugural Keystone Symposia scientific conference in Vienna, to be held November 11-14, 2018 on the topic of “Rare to Care: Discovery, Modeling and Translation of Rare Diseases.” The four-day conference is organized by Dr. Josef M. Penninger of the Institute of Molecular Biotechnology GmbH and Dr. Kym Boycott of Canada’s CHEO Research Institute and will take place in the IMP Lecture Hall. The conference will examine the current and future bottlenecks to gene discovery, disease modeling, and therapeutic approaches for the estimated 7,000 known rare diseases, and suggest strategies to accelerate progress in this regard.

For more information on the program, speakers and deadlines, and to submit an abstract or register, please visit www.keystonesymposia.org/18S4. Scholarships are available for students and postdocs. In addition, learn more about the conference by watching a video interview with Dr. Penninger at http://bit.ly/KSpenninger.

Keystone Symposia on Cellular and Molecular Biology is a 46-year-old organization based in Silverthorne, Colorado, USA that convenes open, peer-reviewed conferences across a broad range of the life sciences. It held its first conference on rare diseases in March 2017 in Boston, Massachusetts, USA.

Deadlines:

Scholarship Deadline: July 25, 2018
Discounted Abstract Deadline: July 25, 2018
Abstract Deadline: August 13, 2018
Discounted Registration Deadline: September 18, 2018 

For more information, please visit www.keystonesymposia.org/18S4 and for a flyer, visit http://www.keystonesymposia.org/index.cfm?e=Web.Meeting.Flyer&MeetingID=1645.

Hashtag for this meeting: #KSrare